TD Waterhouse Canada Inc. Purchases 4,436 Shares of SPDR S&P Biotech ETF $XBI

TD Waterhouse Canada Inc. increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 535.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,265 shares of the exchange traded fund’s stock after purchasing an additional 4,436 shares during the period. TD Waterhouse Canada Inc.’s holdings in SPDR S&P Biotech ETF were worth $824,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in XBI. Paragon Private Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at $236,000. Continuum Advisory LLC increased its stake in shares of SPDR S&P Biotech ETF by 389.1% in the 2nd quarter. Continuum Advisory LLC now owns 18,013 shares of the exchange traded fund’s stock worth $2,851,000 after acquiring an additional 14,330 shares in the last quarter. InTrack Investment Management Inc lifted its position in SPDR S&P Biotech ETF by 12.6% during the 2nd quarter. InTrack Investment Management Inc now owns 3,349 shares of the exchange traded fund’s stock valued at $530,000 after acquiring an additional 374 shares during the period. Tranquilli Financial Advisor LLC lifted its position in SPDR S&P Biotech ETF by 5.4% during the 2nd quarter. Tranquilli Financial Advisor LLC now owns 2,926 shares of the exchange traded fund’s stock valued at $463,000 after acquiring an additional 150 shares during the period. Finally, Beacon Financial Advisory LLC bought a new stake in SPDR S&P Biotech ETF during the second quarter worth about $267,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $159.38 on Thursday. The stock has a market cap of $10.41 billion, a PE ratio of 11.47 and a beta of 0.84. SPDR S&P Biotech ETF has a fifty-two week low of $92.64 and a fifty-two week high of $169.89. The firm’s 50-day simple moving average is $158.42 and its two-hundred day simple moving average is $141.39.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.